Bengaluru, April 20, 2016: Solvay Aroma Performance, the worldwide leader in diphenol and derivatives intermediates, announces its plan to build an additional production capacity of Hydroquinone (HQ) in China starting-up in 2018. This investment will be based on an innovative and environmental friendly technology.
In addition, the Global Business Unit will extend its worldwide Methyl hydroquinone (MEHQ also referred as PMP – paramethoxyphenol) capacity. Both projects will support Solvay captive needs as well as the growth of HQ and MEHQ markets, particularly in Asia.
“This decision will strengthen the company leading position in growing markets like Monomer inhibition with a full range of solutions including PTZ coming from Cytec acquisition, Specialty polymers and Coatings applications as well as Food & Feed antioxidants on which we are positioning ourselves” says Dominique Rage, President of the GBU. “This major capacity increase enhances our reliability towards our customers and will allow for new growth opportunities” he adds.
Corporate Comm India (CCI Newswire)
By Dr. Sandhya Rani, Sr. Consultant - Obstetrics & Gynaecology, Aster Women & Children Hospital,…
Coimbatore, December 28, 2024: Sri Ramakrishna Hospital took a proactive approach to combat the rising…
The 22-Year-Old Founder of Generic Aadhaar Distributes Free Cancer Medicines to 87 Patients, Advancing Shri…
Initiative aimed at enhancing workforce skills and competency in line with industry standards so as…
Previously, the patient underwent an above-knee amputation in the USA due to similar complications in the…
New Delhi, December 27, 2024: A team of expert obstetricians & neonatologists at Motherhood Hospitals,…